{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:35:28Z","timestamp":1757540128585},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,8,1]],"date-time":"1986-08-01T00:00:00Z","timestamp":523238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1986,8]]},"DOI":"10.1007\/bf00172881","type":"journal-article","created":{"date-parts":[[2004,8,15]],"date-time":"2004-08-15T08:07:49Z","timestamp":1092557269000},"page":"112-118","source":"Crossref","is-referenced-by-count":11,"title":["Effect of dihydroergosine (DHESN) on the serotoninergic system and behaviour: Is DHESN a new antidepressive agent?"],"prefix":"10.1007","volume":"90","author":[{"given":"Danka","family":"Peri\u010di\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Manev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Levanat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branimi","family":"Jernej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunja","family":"Vuji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neboj\u0161a","family":"Djordjevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00172881_CR1","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.169.3950.1100","volume":"169","author":"GK Aghajanian","year":"1970","unstructured":"Aghajanian GK, Graham AW, Sheard MH (1970) Serotonin containing neurons in brain: Depression of firing by monoamine oxidase inhibitors. Science 169:1100\u20131102","journal-title":"Science"},{"key":"BF00172881_CR2","volume-title":"Aging brain and ergot alkaloids","author":"A Agnoli","year":"1983","unstructured":"Agnoli A, Crepaldi G, Spano PF, Trabucchi M (1983) Aging brain and ergot alkaloids. Raven Press, New York"},{"key":"BF00172881_CR3","first-page":"237","volume":"18","author":"B Bole-Vunduk","year":"1982","unstructured":"Bole-Vunduk B, Erjavec F, Djordjevi\u0107 N, \u010carman-Kr\u017ean M (1982) The effect of hydrogenation and bromination of ergosine derivatives on cardiovascular system of rats. Iugoslav Physiol Pharmacol Acta 18:237\u2013244","journal-title":"Iugoslav Physiol Pharmacol Acta"},{"key":"BF00172881_CR4","unstructured":"Briley M, Moret C (1984) Inhibitory effect of dihydroergocristine on 5-HT release from rat hypothalamic slices. Br J Pharmacol, p 353"},{"key":"BF00172881_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00426743","volume":"57","author":"HR B\u00fcrki","year":"1978","unstructured":"B\u00fcrki HR, Asper H, Ruch W, Z\u00fcger PE (1978) Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25\u2013397 and 29\u2013712: Effects on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacology 57:227\u2013237","journal-title":"Psychopharmacology"},{"key":"BF00172881_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1476-5381.1970.tb10373.x","volume":"39","author":"G Curzon","year":"1970","unstructured":"Curzon G, Green AR (1970) Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 39:653\u2013655","journal-title":"Br J Pharmacol"},{"key":"BF00172881_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0009-8981(76)90348-X","volume":"70","author":"L Demisch","year":"1976","unstructured":"Demisch L, Bochnik HJ, Seiler N (1976) A routine assay procedure for monoamine oxidase and its application to human blood platelets. Clin Chim Acta 70:357\u2013369","journal-title":"Clin Chim Acta"},{"key":"BF00172881_CR8","unstructured":"Djordjevi\u0107 N, Bole-Vunduk B, Miheli\u0107 J, Simon\u0161ek P (1980) The evidence of presynaptic action of ergot alkaloids using methods of electrical stimulation. 11th Yugoslav Symp Biophys, Trogir, Yugoslavia, Abstract, p 1\u20132"},{"key":"BF00172881_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(81)90057-4","volume":"21","author":"K Fuxe","year":"1981","unstructured":"Fuxe K, \u00d6gren S-O, Agnati LF, Eneroth P, Holm AC, Andersson K (1981) Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat. Neurosci Lett 21:57\u201362","journal-title":"Neurosci Lett"},{"issue":"1","key":"BF00172881_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000212301","volume":"24","author":"M Goldstein","year":"1978","unstructured":"Goldstein M, Lew JY, Hata F, Lieberman A (1978) Binding interactions of ergot alkaloids with monoaminergic receptors in the brain. Gerontology 24 (Suppl 1):76\u201385","journal-title":"Gerontology"},{"key":"BF00172881_CR11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0028-3908(84)90096-0","volume":"23","author":"AR Green","year":"1984","unstructured":"Green AR (1984) 5-HT-mediated behaviour. Neuropharmacology 23:1521\u20131528","journal-title":"Neuropharmacology"},{"key":"BF00172881_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1476-5381.1983.tb10044.x","volume":"80","author":"AR Green","year":"1983","unstructured":"Green AR, Heal DJ, Johnson P, Laurence BE, Nimgaonkar VL (1983a) Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine-and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br J Pharmacol 80:377\u2013385","journal-title":"Br J Pharmacol"},{"key":"BF00172881_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0028-3908(83)90147-8","volume":"22","author":"AR Green","year":"1983","unstructured":"Green AR, O'Shaughnessy K, Hammond M, Sch\u00e4chter M, Grahame-Smith DG (1983b) Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone. Neuropharmacology 22:573\u2013578","journal-title":"Neuropharmacology"},{"key":"BF00172881_CR14","series-title":"Adv Biochem Psychopharmacol","first-page":"199","volume-title":"Serotonin in biological psychiatry","author":"BT Ho","year":"1982","unstructured":"Ho BT, Estevez VS (1982) Molecular aspects of 5-HT uptake inhibitors. In: Ho BT, Schoolar JC, Usdin E (eds) Serotonin in biological psychiatry. Adv Biochem Psychopharmacol, vol 34. Raven Press, New York, pp 199\u2013218"},{"key":"BF00172881_CR15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0024-3205(76)90303-9","volume":"19","author":"BL Jacobs","year":"1976","unstructured":"Jacobs BL (1976) An animal behavior model for studying central serotonergic synapses. Life Sci 19:777\u2013786","journal-title":"Life Sci"},{"key":"BF00172881_CR16","first-page":"54","volume":"19","author":"B Jernej","year":"1983","unstructured":"Jernej B, M\u00fcck-\u0160eler D, Kre\u010d V, Deanovi\u0107 \u017d (1983) Platelet serotonin in the rat: Distribution of normal values and individual variations in time. Iugoslav Physiol Pharmacol Acta 19:54\u201356","journal-title":"Iugoslav Physiol Pharmacol Acta"},{"key":"BF00172881_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0028-3908(81)90038-1","volume":"20","author":"DL Jones","year":"1981","unstructured":"Jones DL, Mogenson GJ, Wu M (1981) Injections of dopaminergic, cholinergic, serotoninergic and GABAergic drugs into the nucleus accumbens: Effects on locomotor activity in the rat. Neuropharmacology 20:29\u201337","journal-title":"Neuropharmacology"},{"key":"BF00172881_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2007-1017363","volume":"18","author":"W Kehr","year":"1985","unstructured":"Kehr W (1985) Receptor-mediated regulation of 5-hydroxytryptamine metabolism: Current knowledge and open questions. Pharmacopsychiatry 18:193\u2013197","journal-title":"Pharmacopsychiatry"},{"key":"BF00172881_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(84)90235-8","volume":"99","author":"NR Kramarcy","year":"1984","unstructured":"Kramarcy NR, Brown JW, Thurmond JB (1984) Effects of drug-induced changes in brain monoamines on aggression and motor behavior in mice. Eur J Pharmacol 99:141\u2013151","journal-title":"Eur J Pharmacol"},{"key":"BF00172881_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0014-2999(70)90185-8","volume":"13","author":"O Lingjaerde Jr","year":"1970","unstructured":"Lingjaerde O Jr (1970) Effects of ergotamine and dihydroergotamine on uptake of 5-hydroxytryptamine in blood platelets. Eur J Pharmacol 13:76\u201382","journal-title":"Eur J Pharmacol"},{"key":"BF00172881_CR21","first-page":"1080","volume":"26","author":"DM Loew","year":"1976","unstructured":"Loew DM, Depoortere H, B\u00fcrki HR (1976) Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat. Arzneim Forsch 26:1080\u20131083","journal-title":"Arzneim Forsch"},{"key":"BF00172881_CR22","series-title":"Adv Biochem Psychopharmacol","first-page":"297","volume-title":"Serotonin: new vistas","author":"L Maitre","year":"1974","unstructured":"Maitre L, Waldmeier PC, Baumann PA, Staehelin M (1974) Effect of maprotiline, a new antidepressant drug, on serotonin uptake. In: Costa E, Gessa GL, Sandler M (eds) Serotonin: new vistas. Adv Biochem Psychopharmacol, vol 10. Raven Press, New York, pp 297\u2013304"},{"key":"BF00172881_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00515596","volume":"306","author":"EJ Marco","year":"1979","unstructured":"Marco EJ, Meek JL (1979) The effects of antidepressants on serotonin turnover in discrete regions of rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 306:75\u201379","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF00172881_CR24","first-page":"706","volume":"229","author":"GE Martin","year":"1984","unstructured":"Martin GE, Bendesky RJ (1984) Mouse locomotor activity: An in vivo test for dopamine autoreceptor activation. J Pharmacol Exp Ther 229:706\u2013711","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00172881_CR25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0006-2952(71)90155-9","volume":"20","author":"JL Meek","year":"1971","unstructured":"Meek JL, Fuxe K (1971) Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some antidepressants and halucinogens. Biochem Pharmacol 20:693\u2013706","journal-title":"Biochem Pharmacol"},{"key":"BF00172881_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00414413","volume":"23","author":"K Modigh","year":"1972","unstructured":"Modigh K (1972) Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia 23:48\u201354","journal-title":"Psychopharmacologia"},{"key":"BF00172881_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(84)90459-X","volume":"97","author":"T Nagatani","year":"1984","unstructured":"Nagatani T, Sugihara T, Kodaira R (1984) The effect of diazepam and of agents which change GABAergic functions in immobility in mice. Eur J Pharmacol 97:271\u2013275","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"BF00172881_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0773.1985.tb02503.x","volume":"56","author":"SO \u00d6gren","year":"1985","unstructured":"\u00d6gren SO, Fuxe K, Agnati LF, Celani MF (1985) Effects of antidepressant drugs on cerebral serotonin receptor mechanisms. Acta Pharmacol Toxicol 56 [Suppl] 1:105\u2013127","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00172881_CR29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ddr.430040602","volume":"4","author":"R Ortmann","year":"1984","unstructured":"Ortmann R (1984) The 5-HT syndrome in rats as tool for the screening of psychoactive drugs. Drug Dev Res 4:593\u2013606","journal-title":"Drug Dev Res"},{"key":"BF00172881_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-2007-1017364","volume":"18","author":"R Ortmann","year":"1985","unstructured":"Ortmann R (1985) The 5-HT syndrome and drug discrimination paradigm in rats: Application in behavioral studies on the central 5-HT system. Pharmacopsychiatry 18:198\u2013201","journal-title":"Pharmacopsychiatry"},{"key":"BF00172881_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000468469","volume":"16","author":"D Peri\u010di\u0107","year":"1981","unstructured":"Peri\u010di\u0107 D (1981a) Dihydroergotoxine and the seizure threshold. Int Pharmacopsychiatry 16:10\u201320","journal-title":"Int Pharmacopsychiatry"},{"key":"BF00172881_CR32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.2042-7158.1981.tb13893.x","volume":"33","author":"D Peri\u010di\u0107","year":"1981","unstructured":"Peri\u010di\u0107 D (1981b) Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions. J Pharm Pharmacol 33:655\u2013659","journal-title":"J Pharm Pharmacol"},{"key":"BF00172881_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00427963","volume":"80","author":"D Peri\u010di\u0107","year":"1983","unstructured":"Peri\u010di\u0107 D, Manev H (1983) Effects of dihydroergotoxine on the susceptibility of rats to convulsions produced by different convulsant agents. Psychopharmacology 80:171\u2013173","journal-title":"Psychopharmacology"},{"key":"BF00172881_CR34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.7221567","volume":"212","author":"SJ Peroutka","year":"1981","unstructured":"Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:827\u2013829","journal-title":"Science"},{"key":"BF00172881_CR35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfe M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"BF00172881_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"key":"BF00172881_CR37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.2042-7158.1984.tb04883.x","volume":"36","author":"S Radulovi\u0107","year":"1984","unstructured":"Radulovi\u0107 S, Djordjevi\u0107 N, Ka\u017ei\u0107 T (1984) The effect of ergot alkaloids ergosinine, dihydroergosine and dihydroergotamine on neurotransmission and contractility of the isolated ileum of the guinea-pig. J Pharm Pharmacol 36:814\u2013819","journal-title":"J Pharm Pharmacol"},{"key":"BF00172881_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-66775-6_2","volume-title":"Ergot alkaloids and related compounds","author":"J Rutschmann","year":"1978","unstructured":"Rutschmann J, Stadler PA (1978) Chemical background. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin, pp 29\u201385"},{"key":"BF00172881_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(79)90333-9","volume":"58","author":"EK Silbergeld","year":"1979","unstructured":"Silbergeld EK, Hruska R (1979) Effects of ergot drugs on serotonergic function: Behavior and neurochemistry. Eur J Pharmacol 58:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"BF00172881_CR40","first-page":"339","volume":"206","author":"RS Sloviter","year":"1978","unstructured":"Sloviter RS, Drust EG, Connor JD (1978) Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther 206:339\u2013347","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00172881_CR41","series-title":"Adv Biochem Psychopharmacol","first-page":"183","volume-title":"Serotonin in biological psychiatry","author":"SM Stahl","year":"1982","unstructured":"Stahl SM, Ciaranello RD, Berger PA (1982) Platelet serotonin in schizophrenia and depression. In: Ho BT, Schoolar JC, Usdin E (eds) Serotonin in biological psychiatry. Adv Biochem Psychopharmacol, vol 34. Raven Press, New York, pp 183\u2013198"},{"key":"BF00172881_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000138016","volume":"29","author":"D Su\u0161i\u0107","year":"1984","unstructured":"Su\u0161i\u0107 D, Djordjevi\u0107 N, Kentera D (1984) Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive rat. Pharmacology 29:215\u2013223","journal-title":"Pharmacology"},{"key":"BF00172881_CR43","first-page":"403","volume":"6","author":"MD Tricklebank","year":"1985","unstructured":"Tricklebank MD (1985) The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. TIPS 6:403\u2013407","journal-title":"TIPS"},{"key":"BF00172881_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.2042-7158.1982.tb04682.x","volume":"34","author":"M Williams","year":"1982","unstructured":"Williams M, Martin GE (1982) Selectivity of cyproheptadine as assessed by radioligand binding. J Pharm Pharmacol 34:58\u201359","journal-title":"J Pharm Pharmacol"},{"key":"BF00172881_CR45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-2999(85)90399-1","volume":"109","author":"WA Wolf","year":"1985","unstructured":"Wolf WA, Youdim MBH, Kuhn DM (1985) Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur J Pharmacol 109:381\u2013387","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00172881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00172881\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00172881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:30:57Z","timestamp":1705210257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00172881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,8]]}},"alternative-id":["BF00172881"],"URL":"https:\/\/doi.org\/10.1007\/bf00172881","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,8]]}}}